Health Catalyst (HCAT) Reports In-Line Q3 EPS

Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $76.32 million versus the consensus estimate of $75.9 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Phillips 66, Marathon Merger Talks Collapsed - Semafor
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15